港股異動 | 中金公司跌5% 擬折價配股淨籌逾25億港元
格隆匯10月17日丨中金公司(3908.HK)現跌5.02%,報14.76港元,暫成交3038.7萬港元,最新總市值618.8億港元。公司昨日公告稱,擬按配售價14.4港元配售1.76億股新H股,淨籌25.02億港元。配售價14.4港元較當日收市價折讓7.34%,配售股份分別佔經配發及發行配售股份擴大後的公司已發行H股總數及已發行股份總數約9.245%及4.029%。籌集資金淨額將用於補充公司資本金、支持公司境內外的現有業務和新業務發展,進一步加強在國際化等戰略領域的資源投入,並把握戰略性併購機會。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.